SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-042440
Filing Date
2024-04-08
Accepted
2024-04-08 09:15:10
Documents
14
Period of Report
2024-04-08
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20240408.htm   iXBRL 8-K 47871
2 EX-3.1 tcon-ex3_1.htm EX-3.1 17886
3 EX-99.1 tcon-ex99_1.htm EX-99.1 19148
4 GRAPHIC img65184791_0.jpg GRAPHIC 23452
  Complete submission text file 0000950170-24-042440.txt   240016

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20240408.xsd EX-101.SCH 24869
17 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20240408_htm.xml XML 4731
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 24828309
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)